Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis

Sun,Tao; Jia,Yanfei; Xiao,Dongjie

doi:10.3892/or.2015.3994

Interference of STAT 5b expression enhances the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis

Authors:
- Tao Sun
- Yanfei Jia
- Dongjie Xiao
View Affiliations

Affiliations: Department of Laboratory Medicine, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong 250014, P.R. China, Central Laboratory, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China
Published online on: May 19, 2015 https://doi.org/10.3892/or.2015.3994
Pages: 227-234

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Signal transducer and activator of transcription (STAT) 5, including STAT 5a and STAT 5b, was reported to play important roles in the malignant biological behaviors of tumors. However, their roles in gastric cancer, especially for STAT 5b remain unknown. This study aimed to detect the expression of STAT 5b in gastric cancer cells and analyze the role and possible mechanism of STAT 5b in the chemo-sensitivity of gastric cancer cells to gefitinib. A total of 69 patients with gastric carcinomas were analyzed for the expression of STAT 5b in carcinomas and para-carcinomas by immunohistochemistry. Cultured MGC-803 and MKN-45 cells were exposed to gefitinib and/or STAT 5b siRNA. Mitochondrial proteins including Bcl-2, Bax, caspase-3 and caspase-9 were extracted using special kits for detecting mitochondrial pathway-related apoptosis proteins. The results showed that STAT 5b expression was significantly increased in gastric carcinomas compared with para-carcinomas, with a positive rate of 49/69 in carcinomas and 27/69 in para-carcinomas (P=0.001). Gefitinib exposure reduced the relative viabilities of MGC-803 and MKN-45 cells in a concentration- and time-dependent manner, and cell apoptosis increased significantly (P<0.05) with gefitinib treatment (4 mM, 24 h). STAT 5b expression was significantly downregulated by treatment with gefitinib (4 mM, 24 h). Interference of STAT 5b expression by siRNA targeting enhanced the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated apoptosis. Bax, caspase-3 and caspase-9 expression were upregulated, and Bcl-2 expression was downregulated in the combined treatment group (gefitinib+siRNA) compared with the gefitinib (4 mM, 24 h) only group in the MGC-803 and MKN-45 cells (P<0.05). Overall, STAT 5b was upregulated in gastric carcinomas compared with para-carcinomas. Interference of STAT 5b expression by siRNA targeting enhanced the chemo-sensitivity of gastric cancer cells to gefitinib by promoting mitochondrial pathway-mediated cell apoptosis. These findings may be useful for developing new approaches for the treatment of gastric cancer.

View Figures

View References

1	Böhmer FD and Friedrich K: Protein tyrosine phosphatases as wardens of STAT signaling. JAK-STAT. 3:e280872014. View Article : Google Scholar : PubMed/NCBI
2	Becerra-Díaz M, Valderrama-Carvajal H and Terrazas LI: Signal transducers and activators of transcription (STAT) family members in helminth infections. Int J Biol Sci. 7:1371–1381. 2011. View Article : Google Scholar : PubMed/NCBI
3	Calò V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N and Russo A: STAT proteins: From normal control of cellular events to tumorigenesis. J Cell Physiol. 197:157–168. 2003. View Article : Google Scholar : PubMed/NCBI
4	Gao B, Wang H, Lafdil F and Feng D: STAT proteins - key regulators of anti-viral responses, inflammation, and tumorigenesis in the liver. J Hepatol. 57:430–441. 2012. View Article : Google Scholar : PubMed/NCBI
5	Sobti RC, Singh N, Hussain S, Suri V, Bharadwaj M and Das BC: Deregulation of STAT-5 isoforms in the development of HPV-mediated cervical carcinogenesis. J Recept Signal Transduct Res. 30:178–188. 2010. View Article : Google Scholar : PubMed/NCBI
6	Yan S, Li B, Bai ZZ, Wu JQ, Xie DW, Ma YC, Ma XX, Zhao JH and Guo XJ: Clinical epidemiology of gastric cancer in Hehuang valley of China: A 10-year epidemiological study of gastric cancer. World J Gastroenterol. 20:10486–10494. 2014. View Article : Google Scholar : PubMed/NCBI
7	Shen L, Shan YS, Hu HM, Price TJ, Sirohi B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of gastric cancer in Asia: Resource-stratified guidelines. Lancet Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
8	Rahman AF, Korashy HM and Kassem MG: Gefitinib. Profiles Drug Subst Excip Relat Methodol. 39:239–264. 2014. View Article : Google Scholar : PubMed/NCBI
9	Blumenberg M: Differential transcriptional effects of EGFR inhibitors. PLoS One. 9:e1024662014. View Article : Google Scholar : PubMed/NCBI
10	Baik M, Yu JH and Hennighausen L: Growth hormone-STAT 5 regulation of growth, hepatocellular carcinoma, and liver metabolism. Ann NY Acad Sci. 1229:29–37. 2011. View Article : Google Scholar
11	Bourgeais J, Gouilleux-Gruart V and Gouilleux F: Oxidative metabolism in cancer: A STAT affair? JAK-STAT. 2:e257642013. View Article : Google Scholar
12	Quintás-Cardama A and Verstovsek S: Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res. 19:1933–1940. 2013. View Article : Google Scholar : PubMed/NCBI
13	Hennighausen L and Robinson GW: Interpretation of cytokine signaling through the transcription factors STAT 5A and STAT 5B. Genes Dev. 22:711–721. 2008. View Article : Google Scholar : PubMed/NCBI
14	Mirtti T, Leiby BE, Abdulghani J, Aaltonen E, Pavela M, Mamtani A, Alanen K, Egevad L, Granfors T, Josefsson A, et al: Nuclear STAT 5a/b predicts early recurrence and prostate cancer-specific death in patients treated by radical prostatectomy. Hum Pathol. 44:310–319. 2013. View Article : Google Scholar :
15	Kim DY, Cha ST, Ahn DH, Kang HY, Kwon CI, Ko KH, Hwang SG, Park PW, Rim KS and Hong SP: STAT3 expression in gastric cancer indicates a poor prognosis. J Gastroenterol Hepatol. 24:646–651. 2009. View Article : Google Scholar : PubMed/NCBI
16	Peck AR, Witkiewicz AK, Liu C, Klimowicz AC, Stringer GA, Pequignot E, Freydin B, Yang N, Ertel A, Tran TH, et al: Low levels of STAT 5a protein in breast cancer are associated with tumor progression and unfavorable clinical outcomes. Breast Cancer Res. 14:R1302012. View Article : Google Scholar
17	Kaymaz BT, Selvi N, Gündüz C, Aktan C, Dalmızrak A, Saydam G and Kosova B: Repression of STAT3, STAT 5A, and STAT 5B expressions in chronic myelogenous leukemia cell line K-562 with unmodified or chemically modified siRNAs and induction of apoptosis. Ann Hematol. 92:151–162. 2013. View Article : Google Scholar
18	Du W, Wang YC, Hong J, Su WY, Lin YW, Lu R, Xiong H and Fang JY: STAT 5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species. J Cell Physiol. 227:2421–2429. 2012. View Article : Google Scholar
19	Riggins RB, Thomas KS, Ta HQ, Wen J, Davis RJ, Schuh NR, Donelan SS, Owen KA, Gibson MA, Shupnik MA, et al: Physical and functional interactions between Cas and c-Src induce tamoxifen resistance of breast cancer cells through pathways involving epidermal growth factor receptor and signal transducer and activator of transcription 5b. Cancer Res. 66:7007–7015. 2006. View Article : Google Scholar : PubMed/NCBI
20	Shi M, Cooper JC and Yu CL: A constitutively active Lck kinase promotes cell proliferation and resistance to apoptosis through signal transducer and activator of transcription 5b activation. Mol Cancer Res. 4:39–45. 2006. View Article : Google Scholar : PubMed/NCBI
21	Ledgerwood EC and Morison IM: Targeting the apoptosome for cancer therapy. Clin Cancer Res. 15:420–424. 2009. View Article : Google Scholar : PubMed/NCBI
22	McCracken JM and Allen LA: Regulation of human neutrophil apoptosis and lifespan in health and disease. J Cell Death. 7:15–23. 2014.PubMed/NCBI
23	Pajak B, Gajkowska B and Orzechowski A: Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol. 46:129–135. 2008. View Article : Google Scholar : PubMed/NCBI
24	Debierre-Grockiego F: Anti-apoptotic role of STAT 5 in haematopoietic cells and in the pathogenesis of malignancies. Apoptosis. 9:717–728. 2004. View Article : Google Scholar : PubMed/NCBI
25	Hardwick JM and Soane L: Multiple functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol. 5:a0087222013. View Article : Google Scholar : PubMed/NCBI
26	Qin S, Yang C, Wang X, Xu C, Li S, Zhang B and Ren H: Overexpression of Smac promotes Cisplatin-induced apoptosis by activating caspase-3 and caspase-9 in lung cancer A549 cells. Cancer Biother Radiopharm. 28:177–182. 2013. View Article : Google Scholar